Appili Therapeutics Inc.
APLIF
$0.0264
-$0.0018-6.38%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 84.62% | 36.84% | 41.40% | -1.93% | -53.70% |
| Total Depreciation and Amortization | -3.85% | 0.00% | 116.67% | 9.09% | -8.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 379.27% | -106.72% | -69.19% | 367.94% | -31.39% |
| Change in Net Operating Assets | -57.43% | 188.25% | -401.88% | -79.18% | 172.76% |
| Cash from Operations | 205.26% | 88.26% | -83.70% | -16.28% | 70.26% |
| Capital Expenditure | -- | 100.00% | -860.87% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -351.02% | -- | 100.00% |
| Total Debt Issued | -100.00% | 0.00% | -94.00% | -- | -- |
| Total Debt Repaid | -41.92% | 14.66% | -4.04% | -2.76% | -2.84% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.78% | 3.65% | 94.01% | -1,463.41% | 3.30% |
| Cash from Financing | -140.46% | 4.00% | -94.98% | 5,228.30% | 4.01% |
| Foreign Exchange rate Adjustments | -133.33% | -40.00% | 126.32% | -272.73% | -82.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 263.41% | 93.56% | -288.55% | 204.45% | 69.33% |
